Skip to main content
Clinical Trials/DRKS00033175
DRKS00033175
Recruiting
Not Applicable

Sleep quality and quality of life with long-term drug therapy for moderate to severe insomnia

Charité-Universitätsmedizin Berlin0 sites105 target enrollmentDecember 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
F51.0
Sponsor
Charité-Universitätsmedizin Berlin
Enrollment
105
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with chronic insomnia according to the ICSD\-3 definition
  • \- Insomnia severity moderate to severe (ISI \> 14\)
  • \- Written consent of the patient after verbal and written information
  • \- no previous drug therapy for moderate to severe insomnia for at least 3 months

Exclusion Criteria

  • \- Patients who have already received any type of therapy for moderate to severe insomnia without subjective and objective benefit
  • \- Patients with severe, life\-limiting illnesses and symptoms that significantly impair sleep, independent of insomnia, such as malignant diseases, pain disorders, unstable or exacerbated illnesses, etc.
  • \- Alcohol or drug abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials